研究

Hirota M, Shimosegawa T, Kitamura K, Takeda K, Takeyama Y, Mayumi T, Ito T, Takenaka M, Iwasaki E, Sawano H, Ishida E, Miura S, Masamune A, Nakai Y, Mitoro A, Maguchi H, Kimura K, Sanuki T, Ito T, Haradome H, Kozaka K, Gabata T, Kataoka K, Hirota M, Isaji S, Nakamura R, Yamagiwa K, Kayaba C, Ikeda K

Continuous regional arterial infusion versus intravenous administration of the protease inhibitor nafamostat mesylate for predicted severe acute pancreatitis: a multicenter, randomized, open-label, phase 2 trial

Yoshida Y, Matsumoto I, Matsumoto M, Kawaguchi K, Murase T, Kamei K, Satoi S, Takebe A, Nakai T, Takeyama Y

Transpancreatic mattress suture with Vicryl mesh around the stump decreases postoperative pancreatic fistula after distal pancreatectomy

a multicenter case-control study of 240 patients Aoki S, Murakami Y, Sho M, Honda G, Uemura K, Okada K, Matsumoto I, Nagai M, Yanagimoto H, Kurata M, Fukumoto T, Mizuma M, Yamaue H, Unno M

Decreased serum carbohydrate antigen 19-9 levels after neoadjuvant therapy predicts a better prognosis for patients with pancreatic adenocarcinoma:

Kansai Hepato-Biliary Oncology Group Kobayashi S, Nagano H, Tomokuni A, Gotoh K, Sakai D, Hatano E, Seo S, Terajima H, Uchida Y, Ajiki T, Satake H, Kamei K, Tohyama T, Hirose T, Ikai I, Morita S, Ioka T, Kansai Hepato-Biliary Oncology (KHBO) Group

A prospective, randomized phase II study of adjuvant gemcitabine versus S-1 after major heapatectomy for biliary tract cancer (KHBO 1208)

Shirasu H, Todaka A, Omae H, Fujii H, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Yukisawa S, Kobayashi M, Fukutomi A

The impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX

Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno. The Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of AdjuvantTherapy for Pancreatic cancer (JSAP)

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05)

Motoi F, Satoi S, Honda G, Wada K, Shinchi H, Matsumoto I, Sho M, Tsuchida A, Unno M, For the Study Group of Preoperative therapy for Pancreatic cancer (PREP)

A single-arm, phase II trial of neoadjuvant gemcitabine and S1 in patients with resectable and borderline resectable pancreatic adenocarcinoma: PREP-01 study.

Motoi F, Murakami Y, Okada KI, Matsumoto I, Uemura K, Satoi S, Sho M, Honda G, Fukumoto T, Yanagimoto H, Kinoshita S, Kurata M, Aoki S, Mizuma M, Yamaue H, Unno M; Multicenter Study Group of Pancreatobiliary Surgery (MSG-PBS)

Sustained elevation of postoperative serum level of carbohydrate antigen 19-9 is high-risk stigmata for primary hepatic recurrence in patients with curatively resected pancreatic adenocarcinoma.

Matsumoto I, Kamei K, Satoi S, Murase T, Matsumoto M, Kawaguchi K, Yoshida Y, Iwasaki T, Takebe A, Nakai T, Takeyama Y.

Laparoscopic versus open distal pancreatectomy for benign and low-grade malignant lesions of the pancreas: a single-center comparative study.

Matsumoto I, Kamei K, Omae K, Suzuki S, Matsuoka H, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi M, Todaka A, Fukutomi A

FOLFIRINOX for locally advanced pancreatic cancer: results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan.

Matsumoto I, Kamei K, Takebe A, Takeyama Y

Laparoscopic distal pancreatectomy for elderly patients.

A case report Iwasaki T, Takeyama Y, Yoshida Y, Kawaguchi, Matsumoto M, Murase T, Kamei K, Takebe A, Matsumoto I, Nakai T

Identification of aberrant subvesical bile duct by using intraoperative fuluorescent cholangiography

Flores K, Cheng Z, Jasper AM, Natori K, Okamoto T, Tanabe A, Gotoh K, Shibata H, Sakurai A, Nakai T, Wang X, Zethoven M, Balachander S, Aita Y, Young W, Zheng S, Takekoshi K, Nakamura E, Tothill RW, Aruiar RCT, Patricia LM, Dahia PLM.

A synonymous VHL variation in exon 2 confuse susceptibility to familial phenochromocytoma and Von Hippel-Lindau Disease

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

POGLUT1, the putative effector gene driven by rs22993370 in primary biliary cholamgitis susceptibility locus chromosome 3q13.33

Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M, Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T

Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan.

Takahashi K, Kondo M, Ando M, Shiraki A, Nakashima H, Wakayama H, Kataoka K, Yamamoto M, Sugino Y, Nishikawa M, Imaizumi K, Kojima E, Sumida A, Takeyama Y, Saito H, Hasegawa Y.

Effects of oral morphine on dyspnea in patients with cancer: Response rate predictive factors, and clinically meaningful change (CJLSG1101)

Morihara D, Ko YL, Shibata K, Yamauchi R, Fukuda H, Tsuchiya N, Fukunaga A, Kunimoto H, Iwashita H, Takata K, Tanaka T, Sakurai K, Inomata S, Yokoyama K, Nishizawa S, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S.

IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment.

Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S

Changes in the serum hepcidin-to-ferritin ratio with erythroferrone after hepatitis C virus eradication using direct-acting antiviral agents

Masamune A, Nabeshima T, Kikuta K, Hamada S, Nakano E, Kume K, Kanno A, Sato A, Tachibana Y, Inatomi O, Yamamoto S, Ikeura T, Futagami S, Taguchi M, Hanada K, Shimizu K, Kageoka M, Saito T, Eguchi T, Kubota K, Takenaka M, Mima A, Irisawa A, Ito T, Andoh A, Inui K, Takeyama Y, Yamaue H, Okazaki K, Shimosegawa T

Prispective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria

Odagiri A, Yamaoka A, Miyata K, Bunya N, Kasai T, Takeyama Y, Uemura S, Mikami T, Narimatsu E

Elderly-onset acute necrotizing encephalopathy mimicking severe heat stroke: a case report and review of the literature

正宗　淳、入澤篤志、菊田和宏、池浦　司、伊佐地秀司、石黒　洋、糸井隆夫、伊藤鉄英、乾　和郎、大原弘隆、片岡慶正、神澤輝実、岸和田昌之、北野雅之、坂上順一、佐田尚宏、清水京子、竹中　完、竹山宜典、能登原憲司、廣岡芳樹、松本逸平、宮川宏之、岡崎和一

慢性膵炎臨床診断基準

正宗　淳、入澤篤志、菊田和宏、池浦　司、伊佐地秀司、石黒　洋、糸井隆夫、伊藤鉄英、乾　和郎、大原弘隆、片岡慶正、神澤輝実、岸和田昌之、北野雅之、坂上順一、佐田尚宏、清水京子、竹中　完、竹山宜典、能登原憲司、廣岡芳樹、松本逸平、宮川宏之、岡崎和一

特集：慢性膵炎臨床診断基準2019
「慢性膵炎臨床診断基準2019」の背景と概要

竹山宜典

膵切除後の合併症とその対策：膵頭十二指腸切除術後の胃内容排泄遅延

竹山宜典

特集:新　手術記録の書き方 Ⅵ　膵臓の手術
５．膵全摘術

南野佳英、外山博近、松本逸平、福本　巧

特集／膵神経内分泌腫瘍 -診断と治療のパラダイムシフト-
III外科治療　PNETの外科治療前にわかる予後不良因子

川口晃平、竹山宜典

検査項目と異常値からみた緊急・重要疾患レッドページ
第３章消化器疾患　急性膵炎

川口晃平、松本逸平、柏木伸夫、竹山宜典

Q and A: 慢性膵炎急性増悪の治療中に発症した意識障害

亀井敬子、松本逸平、竹山宜典

すぐに使える周術期管理マニュアル: 術式別の術前・術中・術後管理マニュアル
膵　膵全摘術

竹山宜典

特集：膵全摘を考える
序説　今なぜ膵全摘術なのか

竹中　完、中井敦史、吉川智恵、石川　嶺、岡本彩那、山崎友裕、大本俊輔、三長孝輔、鎌田　研、山雄健太郎、亀井敬子、松本逸平、竹山宜典、工藤正俊

特集：膵癌における内視鏡診断・治療の最前線
術後膵液瘻に対する内視鏡的ドレナージの現状

亀井敬子、松本逸平、吉田雄太、川口晃平、松本正孝、村瀬貴昭、里井俊平、武部敦志、中居卓也、竹山宜典

特集：術前治療時代の膵癌診断・治療戦略
術前治療と栄養評価

竹山宜典

急性膵炎の重症化機序

竹山宜典

慢性膵炎の診断と治療のup to date

竹山宜典

膵石に対する外科治療

辻江正徳、文田壮一、石川　原、木谷光太郎、里井俊平、福田周一、真鍋弘暢、明石雄策、若狭朋子、塩野裕之、田村孝雄、湯川真生、井上雅智

当院における再発・切除不能膵癌に対する一次化学療法としてのFOLFIRINOX療法の治療成績

竹山宜典

急性膵炎